Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DFB Pharmaceuticals Inc.

www.dfb.com

Latest From DFB Pharmaceuticals Inc.

Symetis: Well-Positioned Next-Generation TAVI Player

Now among the most promising of an emerging group of second-generation transcatheter aortic valve implantation (TAVI) companies, Symetis didn’t start out that way. It began as a cell therapy company, but its initial technology failed. On the verge of running out of money, CEO Jacques Essinger, PhD, engineered a change of direction that ultimately turned Symetis into a TAVI company with the kinds of advantages that may provide it with a competitive advantage.

Medical Device Europe
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • DFB Pharmaceuticals Inc.
  • Senior Management
  • H. Paul Dorman, Chmn. & CEO
  • Contact Info
  • DFB Pharmaceuticals Inc.
    Phone: (817) 900-4000
    3909 Hulen St.
    Fort Worth, TX 76107
    USA
UsernamePublicRestriction

Register